David Knezevic, CTO, Akselos
"Trends in Wellness Investments", David T. Thibodeau, Managing Director, Wellvest Capital
Synthetic Biology Workshop 2017 - Panel Discussion
P&G is looking for new approaches and technologies that can help them to address key business challenges/opportunities.
Christina Qi, Partner, Domeyard LP
Marcus Dahllöf - Introductory Remarks
Yet-Ming Chiang, Cofounder & Chief Scientist, 24M Rick Feldt, President, 24M